DAU 6285

Subscribe to Selected New Research on DAU 6285

3 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Also Known As:

DAU-6285; endo-6-methoxy-8-methyl-8-azabicyclo(3.2.1)oct-3-yl-2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylate HCl; 1H-Benzimidazole-1-carboxylic acid, 2,3-dihydro-6-methoxy-2-oxo-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, monohydrochloride, endo-

Bio-Agent Context: Research Results

Related Diseases

1.	Tachycardia (Tachyarrhythmias) 03/23/1993 - "The novel 5-HT4 receptor antagonist DAU 6285 antagonizes 5-hydroxytryptamine-induced tachycardia in pigs." Get all the results and reference details, order at left...
2.	Hyperventilation 01/01/1996 - "The 5-hydroxytryptamine-induced hyperventilation was blocked by the 5-HT3-receptor antagonists metoclopramide (1.0 mg.kg-1) or MDL72222 (1.0 mg.kg-1), and was insensitive to the 5-HT1/2-receptor antagonist methysergide (3.0 mg.kg-1) and to the 5-HT4-receptor antagonist DAU 6285 CL (3.0 mg.kg-1)" Get all the results and reference details, order at left...
3.	Diarrhea 11/01/1994 - "DAU 6285 significantly inhibited 16,16-dimethyl prostaglandin E2-induced diarrhea at the highest dose (3 mg/kg i.p.)" 11/01/1994 - "Pretreatment (5 min before 5-HTP) with DAU 6285, a marginally selective 5-HT4 receptor antagonist, significantly inhibited 5-HTP-induced diarrhea (ID50, 0.58 mg/kg i.p.)" Get all the results and reference details, order at left...
3 Diseases and 3 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	5-HT4 Serotonin Receptors
2.	Metoclopramide (Reglan)
3.	Methysergide (Sansert)
3 Drugs and Important Bio-Agents and 3 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>